Cargando…

TLR2/6 agonists and IFNγ synergize to induce melanoma cells to produce T-cell recruiting chemokines

Detalles Bibliográficos
Autores principales:	Mauldin, Ileana S, Wang, Ena, Deacon, Donna H, Slingluff, Craig L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990299/ http://dx.doi.org/10.1186/2051-1426-1-S1-O17

Ejemplares similares

TLR2/6 agonists and IFN-gamma treatment induces favorable immune cell recruiting signatures from melanoma associated with STAT1 and IL-32 signaling
por: Mauldin, Ileana S, et al.
Publicado: (2014)

Intratumoral IFN-γ or topical TLR7 agonist promotes infiltration of melanoma metastases by T lymphocytes expanded in the blood after cancer vaccine
por: Tran, Christine A, et al.
Publicado: (2023)

Cytokines and TLR agonists influence the expression of retention integrins CD49a, CD49b and CD103 by T cells
por: Melssen, Marit M, et al.
Publicado: (2015)

Response of human periodontal ligament stem cells to IFN-γ and TLR-agonists
por: Andrukhov, Oleh, et al.
Publicado: (2017)

Identification of the Molecular Mechanism by which TLR Ligation and IFN-γ Synergize to Induce Mig
por: Powell, Jonathan D., et al.
Publicado: (2004)

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
por: Meneveau, Max O, et al.
Publicado: (2021)

Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk
por: Salerno, Elise P., et al.
Publicado: (2016)

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine
por: Mauldin, Ileana S, et al.
Publicado: (2015)

Histone deacetylases inhibitor chidamide synergizes with humanized PD1 antibody to enhance T-cell chemokine expression and augment Ifn-γ response in NK-T cell lymphoma
por: Wen, Tingyu, et al.
Publicado: (2022)

High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS
por: Bracaglia, C, et al.
Publicado: (2015)

IFN-γ and TNF-α Synergize to Inhibit CTGF Expression in Human Lung Endothelial Cells
por: Laug, Roderich, et al.
Publicado: (2012)

Salt suppresses IFNγ inducible chemokines through the IFNγ-JAK1-STAT1 signaling pathway in proximal tubular cells
por: Arai, Yohei, et al.
Publicado: (2017)

Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma
por: Lynch, Kevin T, et al.
Publicado: (2021)

CpG and Interleukin-15 Synergize to Enhance IFN-γ Production by Activated CD8(+) T Cells
por: Cobb, Dustin, et al.
Publicado: (2013)

OX40 agonist immunotherapy expands tumor reactive CD8 T cells with a unique T cell receptor repertoire and synergizes with PDL-1 blockade to promote tumor regression
por: Moran, Amy, et al.
Publicado: (2014)

Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors
por: Albershardt, Tina C., et al.
Publicado: (2020)

Interaction of IFN-γ with Cholinergic Agonists to Modulate Rat and Human Goblet Cell Function
por: García-Posadas, L, et al.
Publicado: (2015)

PD-1, IL-10, IFN-γ and IL-12 form a network to regulate HIV-1-specific CD4 T Cell and antigen-presenting cell function
por: Porichis, F, et al.
Publicado: (2012)

TLR7 Negatively Regulates B10 Cells Predominantly in an IFNγ Signaling Dependent Manner
por: Chodisetti, Sathi Babu, et al.
Publicado: (2020)

IL-17A Synergizes with IFN-γ to Upregulate iNOS and NO Production and Inhibit Chlamydial Growth
por: Zhang, Yongci, et al.
Publicado: (2012)

IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis
por: Mehta, Nehal N., et al.
Publicado: (2017)

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
por: Temizoz, Burcu, et al.
Publicado: (2015)

Agonist anti-4-1BB plus neutralizing anti-CTLA-4 or -PD-L1 synergize to promote tumor regression by rescuing dying dysfunctional CD8+ T cells within the tumor microenvironment
por: Horton, Brendan, et al.
Publicado: (2015)

T Cell Production of IFNγ in Response to TLR7/IL-12 Stimulates Optimal B Cell Responses to Viruses
por: Rubtsova, Kira, et al.
Publicado: (2016)

Superior antiviral and antiproliferative activity of IFN-beta vs. IFN-alpha in primary ATL cells occurs downstream of STAT1 signaling
por: Khouri, Ricardo, et al.
Publicado: (2014)

Role of Cytokines, Chemokines and IFN-γ(+) IL-17(+) Double-Positive CD4(+) T Cells in Patients with Multiple Sclerosis
por: Dias de Sousa, Marlos Aureliano, et al.
Publicado: (2022)

Melanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells
por: Sarrabayrouse, Guillaume, et al.
Publicado: (2010)

Anti interferon-gamma (IFNγ) monoclonal antibody treatment in a patient carrying an NLRC4 mutation and severe hemophagocytic lymphohistiocytosis
por: Bracaglia, C, et al.
Publicado: (2015)

Extramedullary Myelopoiesis in Malaria Depends on Mobilization of Myeloid-Restricted Progenitors by IFN-γ Induced Chemokines
por: Belyaev, Nikolai N., et al.
Publicado: (2013)

Extremely potent immunotherapeutic activity of a STING agonist in the B16 melanoma model in vivo
por: Corrales, Leticia, et al.
Publicado: (2013)

TLR4-induced IFN-γ production increases TLR2 sensitivity and drives Gram-negative sepsis in mice
por: Spiller, Stephan, et al.
Publicado: (2008)

TLR4-induced IFN-γ production increases TLR2 sensitivity and drives Gram-negative sepsis in mice
por: Spiller, Stephan, et al.
Publicado: (2008)

Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas
por: Edmonds, Nicole L., et al.
Publicado: (2023)

IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin
por: Lane, Ryan S., et al.
Publicado: (2018)

IFNγ score–based neoadjuvant immunotherapy for stage III melanoma
por: Fukuda, Keitaro
Publicado: (2023)

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients
por: Melssen, Marit M., et al.
Publicado: (2019)

IFN-γ Mediates the Rejection of Haematopoietic Stem Cells in IFN-γR1-Deficient Hosts
por: Rottman, Martin, et al.
Publicado: (2008)

IFN-γ modulates Ly-49 receptors on NK cells in IFN-γ-induced pregnancy failure
por: Li, Zhong-Yin, et al.
Publicado: (2015)

Innate Cytokine Induced Early Release of IFNγ and CC Chemokines from Hypoxic Human NK Cells Is Independent of Glucose
por: Velásquez, Sonia Y., et al.
Publicado: (2020)

Chemokine decoy receptors in inflammation
por: Graham, G
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_u1are9eertl828holqe0otachq